Edwards Lifesciences

Edwards Lifesciences (NYSE: EW) is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that save and enhance lives. Headquartered in Irvine, California, Edwards Lifesciences has extensive operations in North America, Europe, Japan, Latin America and Asia and currently employs about 6,400 individuals worldwide. For us, helping patients is not a slogan – it's our life’s work. From developing devices that replace or repair a diseased heart valve to creating new technologies that monitor vital signs in the critical care setting, we help ensure that patients regain and even improve their quality of life.
Irvine, US
Size (employees)
11,100 (est)+14%
Edwards Lifesciences was founded in 1958 and is headquartered in Irvine, US

Edwards Lifesciences Office Locations

Edwards Lifesciences has office in Irvine
Irvine, US

Edwards Lifesciences Metrics

Edwards Lifesciences Summary

Market capitalization

$19.9 b

Closing share price

Edwards Lifesciences's current market capitalization is $19.9 b.

Edwards Lifesciences Financials

Edwards Lifesciences's revenue is $2 b in FY, 2013 which is a 11.9% decrease from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016


$2 b$2.3 b$2.5 b$3 b

Revenue growth, %


Gross profit

$1.5 b$1.7 b$1.9 b


$515.3 m$1.1 b$622.4 m

Net Income

$391.7 m$811.1 m$494.9 m$569.5 m

Operating cash flow

$109.5 m$233.4 m$64.6 m

Edwards Lifesciences Market Value History

Edwards Lifesciences Online Presence

Edwards Lifesciences News

Edwards Lifesciences Company Life

You may also be interested in